Ciel charlotte

Menu
Menu
Menu
Art Community

CIR-0602K Begins Dosing in Breakthrough T1D-Supported Phase 2 in Type 1 Diabetes

Randomized placebo-controlled studyAssessing 3 months of CIR-0602K for increasing glucose time-in-range, reducing HbA1c and total daily insulin dose, and improving cardiovascular biomarkers and vascular functionSupported by Breakthrough T1D and ongoing at University of Virginia School of MedicineTopline data…

Read the full release →

News provided by PR Newswire.

ethan parkar

Ethan Parker
Ethan Parker covers stories about community life, personal well-being, local initiatives, lifestyle trends, and the people working to create stronger communities. His writing looks for the human element behind larger developments, focusing on practical ideas and meaningful stories. Ethan brings an approachable perspective to subjects involving everyday life, community participation, creativity, and social connection.
View all posts

You Might Also Like